| Literature DB >> 31810496 |
Salahuddin Ahmed1, Jennifer A Applegate2, Dipak K Mitra3, Jennifer A Callaghan-Koru4, Mahfuza Mousumi5, Ahad Mahmud Khan1, Taufique Joarder6, Meagan Harrison2, Sabbir Ahmed7, Nazma Begum1, Abdul Quaiyum8, Joby George7, Abdullah H Baqui9.
Abstract
BACKGROUND: World Health Organization revised the global guidelines for management of possible serious bacterial infection (PSBI) in young infants to recommend the use of simplified antibiotic therapy in settings where access to hospital care is not possible. The Bangladesh Ministry of Health and Family Welfare (MoHFW), Government of Bangladesh (GOB) adopted these guidelines, allowing treatment at first-level facilities. During the first year of implementation, the Projahnmo Study Group and USAID/MaMoni Health Systems Strengthening (HSS) Project supported the MoHFW to operationalize the new guidelines and conducted an implementation research study in selected districts to assess challenges and identify solutions to facilitate scale-up across the country. IMPLEMENTATION SUPPORT: Projahnmo and MaMoni HSS teams supported implementation in three areas: building capacity, strengthening service delivery, and mobilizing communities. Capacity building focused on training paramedics to conduct outpatient management of PSBI cases and developing monitoring and supervision systems. The teams also filled gaps in government supply of essential drugs, equipment, and logistics. Community mobilization strategies to promote care-seeking and referrals to facilities varied across districts; in one district community, health workers made home visits while in another district, the promotion was carried out through community volunteers, village doctors, and through existing community structures.Entities:
Keywords: Implementation research; Outpatient management; Bangladesh; Possible serious bacterial infection; Young infant infection
Mesh:
Substances:
Year: 2019 PMID: 31810496 PMCID: PMC6898944 DOI: 10.1186/s41043-019-0200-6
Source DB: PubMed Journal: J Health Popul Nutr ISSN: 1606-0997 Impact factor: 2.000
Operational algorithm for managing infections in young infants in UH&FWC per the Bangladesh guidelines
| Category | Clinical signs | Management | Follow-up and referral support |
|---|---|---|---|
| Critical illnesses (CI) | • Unconscious/drowsy • Convulsion/history of convulsion • Unable to feed • Persistent vomiting • Central cyanosis • Bulging fontanel • Weight < 1500 g | • The young infant will be administered the 1st dose of injectable gentamicin and oral antibiotic (if possible), advised about the importance of hospitalization and referred urgently to the designated referral facility with a referral slip containing referral notes of SACMO • The mother will be advised on frequent breastfeeding to prevent low blood sugar. She will also be properly advised to keep the baby warm especially during transportation. | • The mobile phone contact number will be kept to follow-up the referral compliance. The phone number of the SACMO will be provided to the family • The UH&FWC service providers will communicate with the Upazila Health Complex (UHC) (referral center) about the case • Necessary support to be provided by UH&FWC service providers or field supervisors to arrange transport for referral |
| Clinical severe infection (CSI)* | • Severe chest in-drawing • Hypothermia (< 95.9 °F or 35.5 °C • Raised temperature (> 99.5 °F or 37.5 °C) • Less movement/movement only when stimulated • Not feeding well (depending on history and observation) | • The case will be administered 1st dose injectable gentamicin and oral amoxicillin, and referred following the above procedure to the nearest UHC for management | • Same as above, the SACMO’s mobile number will be given to caregiver and the case will be followed up over phone to record referral compliance on the day of referral by UH&FWC provider |
In case of referral non-compliance: • The infant will be managed by the SACMO using standard management protocol: o Injection gentamicin I/M once daily at UH&FWC for 2 days o Oral amoxicillin twice daily for 7 days • The family will be counseled and advised to come to the same facility with the baby to receive the 2nd (last) dose of injectable antibiotic and continue oral medicine 12 hourly for total 7 days | • On the 2nd day of treatment, the infant should return to UH&FWC for assessment and 2nd dose injectable gentamicin • On the 4th and 8th day of treatment, follow-up will be conducted to assess condition of the infant • If the baby develops any new symptom (listed symptoms of CSI or CI), does not improve after 4 days of receiving treatment or, is not fully cured after treatment completion (on the 8th day); the family should be advised for immediate notification to the same service provider and to seek care from referral facility | ||
| Isolated fast-breathing as single sign of illness | • Young infants 0–6 days old with fast breathing as the only sign of illness* | • Give 1st dose of oral amoxicillin and refer to UHC | • The mobile phone contact number will be kept to follow-up the referral compliance. The phone number of the SACMO will be provided to the family • The UH&FWC service providers will communicate with the UHC (referral center) about the case |
In case of referral non-compliance: • The infant will be managed by the SACMO using standard management protocol: o Oral amoxicillin (100 mg/kg/day twice daily) for 7 days | • Infant will be followed up on the 4th day and 8th day • If the baby develops any new symptom (listed symptoms of CSI or CI) or, does not improve after 4 days of receiving treatment, or is not fully cured after treatment completion (on 8th day), the family should be advised for immediate notification to the same service provider and to seek care from referral facility | ||
| • Young infants 7–59 days old with fast breathing as the only sign of illness | • No referral, treated with oral amoxicillin (100 mg/kg/day twice daily) for 7 days | • Sick infants with fast-breathing (7–59 days) will be followed up on the 4th day and 8th day | |
| Local bacterial infection | • Umbilical redness • Draining pus from umbilicus • Skin pustule | • No referral, treated with oral amoxicillin (125 mg daily for below 1-month aged infants or infants having less than 4 kg weight and 250 mg for infants aged between 1 and 2 months) for 5 days | • Caregiver will be advised to seek immediate consultation with UH&FWC provider if infant does not improve, new symptoms appear, or condition worsens |
*PSBI cases eligible for simplified antibiotic treatment when hospital referral is not feasible for families
Fig. 1Map of Bangladesh highlighting implementation research study area districts
Data collection activities by study objective
| Study objective | Data collection activities | |
|---|---|---|
| Quantitative | Qualitative | |
| Examine feasibility of implementation of the newly developed infection management guidelines in young infants at UH&FWCs through outpatient services when referral is not accepted | • Health facility assessment | • IDI & FGD with UH&FWC service providers • IDI with MoHFW program implementers • Process documentation of implementation support activities |
| Assess the acceptability of infection management services delivered on an outpatient basis at UH&FWCs among the parents and families of young infants | • Follow-up surveys with caregivers of infection cases in the community | • IDI with caregivers of infection cases |
| Measure caregiver’s knowledge and coverage of infection management for young infants | • Household survey with caregivers of young infants | • FGD with caregivers of young infants |
| Assess the compliance of the families to the referral advice and new treatment regimen for young infant infections delivered at UH&FWCs | • Weekly review of young infant records at UH&FWC • Follow-up surveys with caregivers of infection cases in the community | • IDI with caregivers of infection cases |
| Document the safety of the injectable antibiotic therapies delivered at union level facilities as per national guidelines for infants classified as clinical severe infection who refuse referral advice | • Weekly review of young infant records at UH&FWC • Follow-up surveys with caregivers of infection cases in the community | • IDI with caregivers of infection cases |
| Identify barriers and facilitating factors to implementation of the protocol, and develop strategies to address barriers to be incorporated into national scale-up plans | • Health facility assessment • Follow-up surveys with caregivers of infection cases in the community | • IDI & FGD with UH&FWC service providers • IDI with MoHFW program implementers • Process documentation of implementation support activities |
Fig. 2Adapted “plan-do-study-act” cycle including study activities at each stage. This implementation research study adopted an adapted action learning cycle approach, or a “plan-do-study-act” (PDSA) cycle [25, 26] to guide program learning and inform adjustments to implementation support